Partner
Languages spoken
English | Arabic
Danielle Asaad is a partner in the Global Corporate Practice Group, with a practice focused on private equity and mergers and acquisitions. Her expertise is sought after by private equity sponsors, whom she advises throughout the investment life cycle – from the initial platform company acquisition to the eventual exit. Danielle represents private equity sponsors that invest in life sciences, medtech, bioanalytical products, testing and certification services and specialty business products industries.
Private equity clients turn to Danielle to structure, negotiate and close complex domestic, as well as cross-border mergers and acquisitions, leveraged buyouts and auctions. Her expertise extends to advising portfolio companies on add-on acquisitions, recapitalizations, equity financings, exit preparation, regulatory compliance, corporate governance and management incentive plans.
Danielle has been recognized as a Global Power Player in Private Equity for 2025 by Financier Worldwide and as one of The Best Lawyers in America for Mergers and Acquisitions Law since 2023. She is an adjunct professor at Case Western Reserve University’s School of Law, where she teaches international business transactions, and has served on Law360’s Editorial Advisory Board for Private Equity.
Author, “Chancery Exec Noncompete Ruling Offers PE Buyer Lessons”, Law360, January 2026.
Co-Author, “Document Management Best Practices for Private Equity Sponsors in the Evolving HSR Landscape”, Financier Worldwide, December 2025.
Co-Author, “SEC’s New Rules Impact the Regulation of Private Fund Advisers,” October 2023.
Co-Author, “Update to Main Street Lending Program,” June 2020.
Quoted, “Fed’s Coronavirus Stimulus Offers Taxpayer Cash to Buyout Firm Companies,” The Wall Street Journal, April 16, 2020.
Co-Author, “Main Street Lending Program: Considerations for Private Equity Sponsors,” April 2020.
Quoted, “Private Equity Steps Up Push to Unlock Coronavirus Stimulus,” The Wall Street Journal, April 1, 2020.
Quoted, “Senate’s Coronavirus Stimulus Deal Offers Little Relief for Private Equity,” The Wall Street Journal, March 25, 2020.
Co-Author, “Existing Restrictions May Preclude PE-Backed Small Companies From Getting Relief Under The COVID-19 Stimulus Bill,” March 2020.